Jump Financial, LLC Cytokinetics Inc Transaction History

Jump Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	BUY	$29.46 - $36.61 $54,353 - $67,545	1,845 Added 16.41%	13,085 $385,000
Q3 2023 Nov 07, 2023	BUY	$29.46 - $36.61 $54,353 - $67,545	1,845 Added 16.41%	13,085 $385,000
Q2 2023 Oct 21, 2024	BUY	$32.62 - $40.75 $366,648 - $458,030	11,240 New	11,240 $366,000
Q2 2023 Aug 07, 2023	BUY	$32.62 - $40.75 $366,648 - $458,030	11,240 New	11,240 $366,000
Q1 2022 May 12, 2022	SELL	$29.74 - $46.0 $817,939 - $1.27 Million	-27,503 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$34.35 - $46.38 $944,728 - $1.28 Million	27,503 New	27,503 $1.25 Million
Q3 2021 Nov 12, 2021	SELL	$18.54 - $35.74 $321,706 - $620,160	-17,352 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$19.79 - $26.99 $94,061 - $128,283	4,753 Added 37.73%	17,352 $343,000
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $233,963 - $323,542	12,599 New	12,599 $293,000
Q4 2020 Feb 12, 2021	SELL	$15.26 - $28.61 $364,714 - $683,779	-23,900 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $491,861 - $692,144	23,900 New	23,900 $517,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.